Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Notorious ATG
    Junior Member
    • Mar 2016
    • 3

    #1

    Increased methylation in Dnmt3a knockout mice???

    Hi all,

    I've been working with whole genome bisulfite sequencing data from brain tissue. Our model uses a Cre-lox strategy to knock out Dnmt3a in a specific type of neuron, and we're now comparing genome-wide CpG methylation in control and floxed mice.

    While we don't have any particular genes or genomic contexts we expect to see changes in (which is why we're doing WGBS), we expect at minimum for the knockouts to have less methylation. As it happens, the opposite is the case, and the knockouts pretty clearly have more CpG methylation. Genome-wide the average CpG methylation is a little less than 75% in controls, and around 76-77% in knockouts.

    This is my first time doing such a study, so I'm wondering if anyone can offer some advice on technical reasons that I might be getting these results? What QC measures could give me a hint that the library prep went wrong, or that some kind of bias has entered the equation. It's possible that these results are real, but since they're weird I want to be extra sure no technical errors are the cause.

    Thanks!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...